Physician

Alejandro D Chediak, M.D.

According to 2025 Medicare claims, Alejandro Chediak, M.D. (NPI: 1669401774) practices sleep medicine in the Miami-Miami Beach-Kendall, FL market, with the plurality of this provider's patient population coming from Miami-Dade, FL. This provider's primary affiliated billing organization is UNIVERSITY OF MIAMI (NPI: 1003866617; TIN: 592579938) and primary practice location at 33146-2513.

Chediak's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 456 traditional Medicare patients, billed 755 HCPCS/CPT codes, and received $47,682 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 470 prescription claims across 116 beneficiaries totaling $203,017 in drug costs, led by Belsomra (Suvorexant). DME data shows 5,083 claims. Open Payments data shows 11 records totaling $644. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $140,904 to $47,682. In contrast, Part D prescription costs have moved sharply higher in recent years, from $110,782 to $203,017. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	408	776	$140,904
2016	425	747	$68,382
2017	488	824	$59,353
2018	533	846	$67,245
2019	574	856	$64,421
2020	460	608	$50,886
2021	475	674	$60,646
2022	447	539	$46,656
2023	434	583	$47,359
2024	456	755	$47,682

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	99	551	$110,782
2016	81	430	$96,377
2017	68	280	$101,956
2018	79	323	$105,115
2019	81	344	$122,408
2020	85	358	$126,961
2021	98	388	$141,454
2022	88	390	$158,287
2023	92	416	$200,672
2024	116	470	$203,017

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	2,370	5,148	$198,805
2016	2,129	5,195	$198,786
2017	1,983	4,378	$134,244
2018	2,022	4,204	$134,769
2019	1,878	3,960	$133,924
2020	1,838	3,773	$130,853
2021	1,945	4,149	$151,583
2022	1,896	4,167	$163,415
2023	1,887	4,644	$200,693
2024	2,022	5,083	$237,057

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	39	39	$108
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	302	322	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	38	38	$64
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	31	51	$63
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	192	199	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Belsomra	Suvorexant	31	920	$13,264
Doxepin Hcl	Doxepin Hcl	100	6,220	$10,772
Quviviq	Daridorexant Hcl	20	600	$9,733
Symbicort	Budesonide/Formoterol Fumarate	13	390	$3,135
Ramelteon	Ramelteon	13	391	$1,682

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	291	710	$41,264
E0601	Continuous positive airway pressure (cpap) device	Y	156	962	$34,554
A4604	Tubing with integrated heating element for use with positive airway pressure device	N	293	723	$27,224
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	131	289	$20,081
A7032	Cushion for use on nasal mask interface, replacement only, each	N	92	216	$19,093

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$644	JAZZ PHARMACEUTICALS INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alejandro D. Chediak, M.D.?

Tedicare shows public-source Medicare data for Alejandro D. Chediak, M.D. (NPI 1669401774), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alejandro D. Chediak, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alejandro D. Chediak, M.D.?

Alejandro D. Chediak, M.D. is linked to UNIVERSITY OF MIAMI (billing NPI 1003866617) in the available physician profile data.

Does Alejandro D. Chediak, M.D. have Open Payments data?

Alejandro D. Chediak, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.